SOCAM DEV(00983)
Search documents
瑞安建业(00983) - 截至2026年1月31日止股份发行人的证券变动月报表
2026-02-03 07:45
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2026年1月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致:香港交易及結算所有限公司 | | | | | | | 公司名稱: | 瑞安建業有限公司 | | | | | | 呈交日期: | 2026年2月3日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 00983 | 說明 | | | | | 上月底結存 | 1,000,000,000 | HKD | 1 | HKD | 1,000,000,000 | | --- | --- | --- | --- | --- | --- | | 增加 / 減少 (-) | 0 | | | HKD | | | 本月底結存 | 1,000,000,000 | HKD | 1 | HKD | 1,000,000,000 | 本月底法定/註冊股 ...
瑞安建业(00983) - 截至2025年12月31日止股份发行人的证券变动月报表
2026-01-02 06:52
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 狀態: 新提交 | | --- | | 截至月份: 2025年12月31日 | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 致:香港交易及結算所有限公司 公司名稱: 瑞安建業有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00983 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | | 1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 1,000,000, ...
港股收评:恒指涨0.43%、科指涨0.87%,新消费概念、芯片股及黄金股走高,四只IPO新股集体破发
Jin Rong Jie· 2025-12-22 08:21
Market Overview - The Hong Kong stock market experienced fluctuations on December 22, with the Hang Seng Index rising by 0.43% to close at 25,801.77 points, the Hang Seng Tech Index increasing by 0.87% to 5,526.83 points, and the National Enterprises Index up by 0.43% to 8,939.68 points [1] - Major technology stocks showed mixed performance, with Alibaba up by 0.76%, Tencent Holdings up by 0.08%, and JD Group up by 0.9%, while Xiaomi fell by 1.83% and NetEase by 0.09% [1] - The optical communication sector was strong, with Huiju Technology rising by 13% and Changfei Optical Fiber Cable up by 11% [1] - Duty-free concept leader China Duty Free Group surged over 15%, while the new consumption sector saw significant gains, with Mixue Group up over 10% and Pop Mart up over 4% [1] - Chip stocks also rose, with SMIC increasing by nearly 6% and Hua Hong Semiconductor up over 5% [1] - Gold stocks generally rose, with China National Gold up over 7% and Shandong Gold up over 5% [1] - Four new stocks were listed, including Impression Dahongpao and Huacheng Biotechnology, all of which experienced a decline in their initial trading [1] Company News - SF Holding reported a total revenue of 27.173 billion yuan for November, a year-on-year increase of 7.85%, with express logistics revenue growing by 9.88% and business volume increasing by 20.13% [2] - Capital Venture expects to achieve an unaudited net profit of approximately 115 million to 140 million HKD for the fiscal year ending September 30, 2025, marking a turnaround from losses, primarily due to improved performance in listed equity investments [2] - Tianqi Lithium announced the completion of the third phase of its chemical-grade lithium concentrate expansion project, which has officially commenced trial production [3] - Qingdao Port plans to purchase two assets from the cruise port development for the Qingdao Shipping Financial Center [4] - CanSino Biologics has initiated Phase I clinical trials for its DTCP–HIb–MCV4 combined vaccine, completing the enrollment of the first subject [5] - Junshi Biosciences received FDA approval for the Phase I clinical trial application of its biosimilar HLX18 for the treatment of various solid tumors [5] - China National Nuclear Corporation's subsidiary, CNNC Haidewei, received clinical approval for its BNCT boron drug [6] - Hisense Home Appliances subscribed to a financial product from Jingu Trust worth 1.892 billion yuan [7] - Evergrande Property's liquidator has received several updated non-binding offers from selected bidders, which are currently under consideration [7] - Ruian Construction completed the sale of Ruian Property Management Services [8] - Tianjin Port Development's subsidiary plans to purchase ten gantry cranes for 185 million yuan [9] Institutional Insights - CITIC Securities noted that after a strong rally in September, the Hong Kong market has experienced fluctuations since October due to varying overseas macro expectations, with quality assets becoming more attractive [10] - Huatai Securities indicated that the market is still in a left-side layout phase, with uncertainties surrounding the "Santa rally" and potential supply-demand pressures at year-end [10] - China Galaxy suggested focusing on the technology sector as a long-term investment theme, which has seen valuation corrections and may rebound due to multiple favorable factors [10] - The consumption sector is expected to receive significant policy support, with current valuations at relatively low levels, indicating potential for long-term growth [10]
港股公告精选|顺丰控股11月速运业务量同比增约两成 首都创投预计上一财年业绩扭亏为盈
Xin Lang Cai Jing· 2025-12-19 12:28
Company News - SF Holding (06936.HK) reported a total revenue of 27.173 billion yuan for its express logistics, supply chain, and international business in November, representing a year-on-year growth of 7.85%. The express logistics business revenue grew by 9.88%, with a business volume increase of 20.13% [2] - Capital Investment (02324.HK) expects to achieve an unaudited consolidated net profit of approximately 115 million to 140 million HKD for the fiscal year ending September 30, 2025, marking a turnaround from losses, primarily due to the performance of listed equity investments [2] - Tianqi Lithium (09696.HK) has completed the construction of the third phase of its chemical-grade lithium concentrate expansion project and has officially commenced trial production [2] - Qingdao Port (06198.HK) plans to purchase two assets from the Qingdao Shipping Financial Center for the development of a cruise port [2] - CanSino Biologics (06185.HK) has initiated Phase I clinical trials for its DTCP–HIb–MCV4 combined vaccine and completed the enrollment of the first subject [2] - Fuhong Hanlin (02696.HK) received approval from the U.S. Food and Drug Administration for its application for the Phase I clinical trial of HLX18, a biosimilar to Nivolumab for the treatment of various solid tumors [2] - China National Nuclear Corporation (01763.HK) announced that its subsidiary, CNNC Haidewei, has received clinical approval for its BNCT boron drug [2] - Hisense Home Appliances (00921.HK) subscribed to a financial product from Jingu Trust for 1.892 billion yuan [2] Acquisition and Disposal - Evergrande Property (06666.HK) has received several updated non-binding offers from selected bidders, which the liquidators are currently considering [3] - Ruian Construction (00983.HK) has completed the sale of Ruian Property Management Services Co., Ltd. [4] - Tianjin Port Development (03382.HK) plans to purchase ten gantry cranes for 185 million yuan [5] Buyback Activities - Tencent Holdings (00700.HK) repurchased 1.036 million shares at a cost of 636 million HKD, with buyback prices ranging from 607 to 617 HKD [5] - Xiaomi Group-W (01810.HK) repurchased 3.75 million shares for 152 million HKD, with buyback prices between 40.42 and 40.56 HKD [6] - COSCO Shipping Holdings (01919.HK) repurchased 3.9655 million shares for 53.6689 million HKD, with buyback prices ranging from 13.47 to 13.73 HKD [6] - Kuaishou-W (01024.HK) repurchased 755,000 shares for 49.9509 million HKD, with buyback prices between 65.4 and 66.6 HKD [7]
瑞安建业完成出售瑞安物业管理服务有限公司
Zhi Tong Cai Jing· 2025-12-19 09:43
瑞安建业(00983)发布公告,有关出售瑞安物业管理服务有限公司全部已发行股本,买卖协议项下的所 有先决条件已获达成,并根据买卖协议的条款及条件于2025年12月19日成交。于成交后,目标公司不再 为公司的附属公司,而目标集团的财务业绩将不会再并入公司的财务报表。 ...
瑞安建业(00983)完成出售瑞安物业管理服务有限公司
智通财经网· 2025-12-19 09:37
智通财经APP讯,瑞安建业(00983)发布公告,有关出售瑞安物业管理服务有限公司全部已发行股本,买 卖协议项下的所有先决条件已获达成,并根据买卖协议的条款及条件于2025年12月19日成交。于成交 后,目标公司不再为公司的附属公司,而目标集团的财务业绩将不会再并入公司的财务报表。 ...
瑞安建业(00983) - 完成有关出售附属公司之主要交易
2025-12-19 09:27
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任何部份內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 香港,2025 年 12 月 19 日 於本公佈刊發日期,執行董事為羅康瑞先生(主席)、李進港先生(行政總裁)及羅俊誠先生(副 行政總裁);非執行董事為羅寶瑜女士及陳偉根先生;而獨立非執行董事為陳棋昌先生、劉炳章 先生及王克活先生。 網址: www.socam.com 茲提述瑞安建業有限公司(「本公司」)日期為 2025 年 9 月 8 日的公佈及日 期為 2025 年 10 月 31 日的通函(「該通函」),內容有關出售事項。除文義 另有所指外,本公佈所用詞彙與該通函所界定者具有相同涵義。 董事會欣然宣佈,買賣協議項下的所有先決條件已獲達成,並根據買賣協議的 條款及條件於 2025 年 12 月 19 日成交。於成交後,目標公司不再為本公司之 附屬公司,而目標集團之財務業績將不會再併入本公司之財務報表。 承董事會命 瑞安建業有限公司 執行董事兼行政總裁 李進港 * 僅供識別 瑞安建業有限公司* SOCA ...
瑞安建业(00983) - 截至2025年11月30日止股份发行人的证券变动月报表
2025-12-01 07:42
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致:香港交易及結算所有限公司 公司名稱: 瑞安建業有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00983 | 說明 | | | | | | | | | 已發行股份(不包括庫存股份)數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 373,346,164 | | 0 | | 373,346,164 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 373,346,164 | | 0 | | 373,346,164 | 第 2 頁 共 10 頁 v 1.1.1 FF301 III.已發行股份及/或庫存股份變動詳情 | 1. 股份分類 | ...
瑞安建业(00983) - 须予披露及关连交易 - 收购SHUI ON CONTRACTORS LI...
2025-11-28 10:32
瑞安建業有限公司* SOCAM Development Limited (於百慕達註冊成立的有限公司) (股份代號:983) 須予披露及關連交易 收購 SHUI ON CONTRACTORS LIMITED 的股份權益 茲提述2017年公佈,其內容乃有關(其中包括)(i)出售事項;及 (ii)本公司獲買 方授予認購期權,可於若干特定事件發生(包括但不限於買方與 SOCON集團的 僱傭關係終止)時根據買賣協議收購該等於出售事項中售予買方的SOCON股 份。 於2025年8月31日,區才華先生(為其中一名買方)因退休而不再為SOCON集團 僱員,因此,根據買賣協議,涉及區才華先生於出售事項中購買的1股SOCON股 份的認購期權(即認購期權)已可予行使。 於2025年11月28日,本公司向區才華先生發出認購期權通知,行使認購期權以收 購區才華先生1股SOCON股份(不帶任何產權負擔)(即收購事項),佔 SOCON已發行股本0.5%,代價約為903萬港元。 SOCON集團主要於香港及澳門從事建築、裝修及保養工程。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責,對其準確性或完整性 亦不發表任何 ...
瑞安建业(00983) - 截至2025年10月31日止股份发行人的证券变动月报表
2025-11-03 08:17
公司名稱: 瑞安建業有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00983 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | 1,000,000,000 | | HKD | | 1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 1,000,000,000 | HKD | | 1 | HKD | | 1,000,000,000 | 本月底法定/註冊股本總額: HKD 1,000,000,000 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致:香港交易及結算 ...